SRPT Sarepta Therapeutics Inc.

Sarepta Therapeutics to Announce Third Quarter 2021 Financial Results and Recent Corporate Developments on November 3, 2021

Sarepta Therapeutics to Announce Third Quarter 2021 Financial Results and Recent Corporate Developments on November 3, 2021

CAMBRIDGE, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report third quarter 2021 financial results after the Nasdaq Global Market closes on Wednesday, November 3, 2021. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its third quarter 2021 financial results and to provide a corporate update.

The conference call may be accessed by dialing (844) 534-7313 for domestic callers and (574) 990-1451 for international callers. The passcode for the call is 7131019. Please specify to the operator that you would like to join the "Sarepta Third Quarter 2021 Earnings Call." The conference call will be webcast live under the investor relations section of and will be archived there following the call for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics

Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit  or follow us on , , and .

Internet Posting of Information

We routinely post information that may be important to investors in the 'For Investors' section of our website at . We encourage investors and potential investors to consult our website regularly for important information about us.

Source: Sarepta Therapeutics, Inc.

Investor Contact:

Ian Estepan, 617-274-4052

Media Contact:

Tracy Sorrentino, 617-301-8566



EN
27/10/2021

Underlying

SRPTSarepta Therapeutics Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Sarepta Therapeutics Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 43.14
DHR DANAHER CORPORA...
ANTM ANTHEM INC. ... (+19)

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

DHR DANAHER CORPORATION
ANTM ANTHEM INC.
SRPT SAREPTA THERAPEUTICS INC.
OMC OMNICOM GROUP INC
NEO NEOGENOMICS INC.
IPG INTERPUBLIC GROUP OF COMPANIES INC.
HELE HELEN OF TROY LIMITED
HAL HALLIBURTON COMPANY
AVA AVISTA CORPORATION
ANDE ANDERSONS INC.
ACGL ARCH CAPITAL GROUP LTD.
MDU MDU RESOURCES GROUP INC
POR PORTLAND GENERAL ELECTRIC COMPANY
THS TREEHOUSE FOODS INC.
TNDM TANDEM DIABETES CARE
AVTR AVANTOR INC.
VTRS VIATRIS INC.
REYN REYNOLDS CONSUMER PRODUCTS
VSTS_w VESTIS CORPORATION
10/08/25 October 8, 2025 1 EN
Free Trial
SRPT Sarepta Therape...

Sarepta Therapeutics Inc: 1 director

A director at Sarepta Therapeutics Inc bought 37,038 shares at 133.801USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...

SRPT SAREPTA THERAPEUTICS INC.
08/20/24 August 20, 2024 1 EN
Wedbush Research
  • Wedbush Research
SRPT SAREPTA THERAPEUTICS INC.
SGMO SANGAMO THERAPEUTICS INC.
PCRX PACIRA BIOSCIENCES INC.
MNKD MANNKIND CORP.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
KALA KALA PHARMACEUTICALS INC.
VRNA VERONA PHARMA ADS
UBX UNITY BIOTECHNOLOGY
LQDA LIQUIDIA CORPORATION
IMUX IMMUNIC INC
AQST AQUESTIVE THERAPEUTICS
SBTX SILVERBACK THERAPEUTICS
RANI RANI THERAPEUTICS HLDGS INC
OCS OCULIS HOLDING AG
07/19/24 July 19, 2024 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 43.14
VEC VECTRUS
SRPT Sarepta Therape... ... (+25)

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

VEC VECTRUS
SRPT SAREPTA THERAPEUTICS INC.
SPR SPIRIT AEROSYSTEMS HOLDINGS INC. CLASS A
MNKD MANNKIND CORP.
BCRX BIOCRYST PHARMACEUTICALS INC.
ALNY ALNYLAM PHARMACEUTICALS INC
AGIO AGIOS PHARMACEUTICALS INC.
RY4C RYANAIR HOLDINGS PLC
LILA LIBERTY LATIN AMERICA A
DNLI DENALI THERAPEUTICS INC
ADT ADT INC
HROW HARROW HEALTH INC.
TWST TWIST BIOSCIENCE
DYN DYNE THERAPEUTICS
SMLP SUMMIT MIDSTREAM PARTNERS
RNA AVIDITY BIOSCIENCES
TNGX TANGO THERAPEUTICS INC
RYAN RYAN SPECIALTY GROUP HLDGS INC
RKLB ROCKET LAB USA INC
BTMD HAYMAKER ACQUISITION CORP III
IBRX IMMUNITYBIO INC
CDRO CODERE ONLINE LUXEMBOURG SA
XPOF XPONENTIAL FITNESS INC
UBXG U BX TECHNOLOGY LTD
FTLF FITLIFE BRANDS INC.
06/24/24 June 24, 2024 1 EN
David Carlson ... (+8)
  • David Carlson
  • David Nierengarten
  • Dennis Pak
  • Laura Chico
  • Martin Fan
  • Ritika Das
  • Robert Driscoll
  • Sam Ravina
SRPT SAREPTA THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
KURA KURA ONCOLOGY INC.
GERN GERON CORP.
CMRX CHIMERIX INC
BPMC BLUEPRINT MEDICINES CORP.
ARDX ARDELYX INC
UTHR UNITED THERAPEUTICS CORPORATION
GTHX G1 THERAPEUTICS
SWTX SPRINGWORKS THERAPEUTICS
04/26/24 April 26, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch